These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 15914316

  • 1. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C, Zhang J, Wei H, Tian Z.
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [Abstract] [Full Text] [Related]

  • 2. Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells.
    Zhang C, Zhang J, Sun R, Feng J, Wei H, Tian Z.
    Int Immunopharmacol; 2005 Jun; 5(6):1057-67. PubMed ID: 15829421
    [Abstract] [Full Text] [Related]

  • 3. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H, Kim J, Cosman D, Choi I.
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [Abstract] [Full Text] [Related]

  • 4. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR.
    Cancer Res; 2005 Jul 15; 65(14):6321-9. PubMed ID: 16024634
    [Abstract] [Full Text] [Related]

  • 5. NKG2D and Related Immunoreceptors.
    Strong RK, McFarland BJ.
    Adv Protein Chem; 2004 Jul 15; 68():281-312. PubMed ID: 15500864
    [Abstract] [Full Text] [Related]

  • 6. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.
    Eur J Immunol; 2003 Feb 15; 33(2):381-91. PubMed ID: 12645935
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.
    Romanski A, Bug G, Becker S, Kampfmann M, Seifried E, Hoelzer D, Ottmann OG, Tonn T.
    Exp Hematol; 2005 Mar 15; 33(3):344-52. PubMed ID: 15730858
    [Abstract] [Full Text] [Related]

  • 8. UL16 binding proteins.
    Cao W, He W.
    Immunobiology; 2004 Mar 15; 209(3):283-90. PubMed ID: 15518340
    [Abstract] [Full Text] [Related]

  • 9. NK cells and cancer immunosurveillance.
    Waldhauer I, Steinle A.
    Oncogene; 2008 Oct 06; 27(45):5932-43. PubMed ID: 18836474
    [Abstract] [Full Text] [Related]

  • 10. How NKG2D ligands trigger autoimmunity?
    Caillat-Zucman S.
    Hum Immunol; 2006 Mar 06; 67(3):204-7. PubMed ID: 16698443
    [Abstract] [Full Text] [Related]

  • 11. Innate immune recognition and suppression of tumors.
    Hayakawa Y, Smyth MJ.
    Adv Cancer Res; 2006 Mar 06; 95():293-322. PubMed ID: 16860661
    [Abstract] [Full Text] [Related]

  • 12. NKG2D ligands in tumor immunity.
    Nausch N, Cerwenka A.
    Oncogene; 2008 Oct 06; 27(45):5944-58. PubMed ID: 18836475
    [Abstract] [Full Text] [Related]

  • 13. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.
    Nat Immunol; 2000 Aug 06; 1(2):119-26. PubMed ID: 11248803
    [Abstract] [Full Text] [Related]

  • 14. The role of the NKG2D receptor for tumor immunity.
    Coudert JD, Held W.
    Semin Cancer Biol; 2006 Oct 06; 16(5):333-43. PubMed ID: 16914326
    [Abstract] [Full Text] [Related]

  • 15. NKG2D and cytotoxic effector function in tumor immune surveillance.
    Hayakawa Y, Smyth MJ.
    Semin Immunol; 2006 Jun 06; 18(3):176-85. PubMed ID: 16675266
    [Abstract] [Full Text] [Related]

  • 16. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M.
    Nat Immunol; 2002 Dec 06; 3(12):1150-5. PubMed ID: 12426564
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug 06; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

  • 18. Natural killer cell signaling pathways.
    Vivier E, Nunès JA, Vély F.
    Science; 2004 Nov 26; 306(5701):1517-9. PubMed ID: 15567854
    [Abstract] [Full Text] [Related]

  • 19. NKG2D ligands: key targets of the immune response.
    González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C.
    Trends Immunol; 2008 Aug 26; 29(8):397-403. PubMed ID: 18602338
    [Abstract] [Full Text] [Related]

  • 20. Exosomes and the MICA-NKG2D system in cancer.
    Clayton A, Tabi Z.
    Blood Cells Mol Dis; 2005 Aug 26; 34(3):206-13. PubMed ID: 15885603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.